Indoor Biotechnologies India Private Limited, a struck off private limited company, was established on 28 April 2015 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74900KA2015PTC079960. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.03 M.
It upholds a compliant status. Its leadership includes Madeleine Cicely Watkins (Director), Sivasankar Baalasubramanian (Director), Martin Dudley Chapman (Director). Past directors included James Phillip Hindley. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Egf 3, Bangalore Bioinnovation Centre (Bbc), Bangalore Helix Biotech Park, Electronic, City Ph-1, Bangalore, Karnataka, 560100.
U74900KA2015PTC079960
079960
28 April 2015
₹2.50 M
₹2.03 M
Roc Bangalore
Unlisted
Struck Off
Explore comprehensive insights into Indoor Biotechnologies India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madeleine Cicely Watkins | Director | 08 Jun 2016 | Current |
| Sivasankar Baalasubramanian | Director | 28 Apr 2015 | Current |
| Martin Dudley Chapman | Director | 28 Apr 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indoor Biotechnologies India Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 19.85% decrease. The company also saw a substantial fall in profitability, with a 234.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 343.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Indoor Biotechnologies India had a promoter holding of 62.42% and a public holding of 37.58%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Indoor Biotechnologies India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Indoor Biotechnologies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indoor Biotechnologies India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Indoor Biotechnologies India Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
The activity Indoor Biotechnologies India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was completed.
The activity Madeleine Cicely Watkins was appointed as a Director was appointed as a Director on 08 Jun 2016 & has been associated with this company since 9 years 7 months . was completed.
The activity Sivasankar Baalasubramanian was appointed as a Director was appointed as a Director on 28 Apr 2015 & has been associated with this company since 10 years 8 months . was completed.
Progress on Martin Dudley Chapman was appointed as a Director was appointed as a Director on 28 Apr 2015 & has been associated with this company since 10 years 8 months . was documented.
Progress on Indoor Biotechnologies India Private Limited was registered on 28 Apr 2015 with Roc Bangalore & aged 10 years 8 months as per MCA records. was documented.
The CIN of Indoor Biotechnologies India Private Limited is U74900KA2015PTC079960.
Indoor Biotechnologies India Private Limited is headquartered at Egf 3, Bangalore Bioinnovation Centre (Bbc), Bangalore Helix Biotech Park, Electronic, City Ph-1, Bangalore, Karnataka, 560100.
Indoor Biotechnologies India Private Limited was incorporated on 28 April 2015.
The current directors of Indoor Biotechnologies India Private Limited are
The primary industry of Indoor Biotechnologies India Private Limited is Manufacturing.
Indoor Biotechnologies India Private Limited is unlisted.
The authorized capital of Indoor Biotechnologies India Private Limited is ₹2.50 M, and the paid-up capital is ₹2.03 M.
The compliance status of Indoor Biotechnologies India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX